Gene: Actb-ps9 (actin, beta, pseudogene 9) Rattus norvegicus |
|
Analyze |
|
Symbol: |
Actb-ps9 |
Name: |
actin, beta, pseudogene 9 |
RGD ID: |
1584843 |
Description: |
|
Type: |
pseudo
|
RefSeq Status: |
MODEL |
Previously known as: |
LOC502977; similar to cytoplasmic beta-actin |
Latest Assembly: |
GRCr8 - GRCr8 Assembly |
Position: |
Rat Assembly | Chr | Position (strand) | Source | Genome Browsers |
---|
JBrowse | NCBI | UCSC | Ensembl |
---|
GRCr8 | 5 | 125,887,546 - 125,888,097 (-) | NCBI | | GRCr8 | | | mRatBN7.2 | 5 | 120,658,714 - 120,659,243 (-) | NCBI | mRatBN7.2 | mRatBN7.2 | | | Rnor_6.0 | 5 | 125,373,711 - 125,374,253 (-) | NCBI | Rnor6.0 | Rnor_6.0 | rn6 | Rnor6.0 | Rnor_5.0 | 5 | 129,231,099 - 129,231,618 (-) | NCBI | Rnor5.0 | Rnor_5.0 | rn5 | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,809 - 126,892,290 (-) | NCBI | RGSC3.4 | RGSC_v3.4 | rn4 | RGSC3.4 | Celera | 5 | 119,421,799 - 119,422,341 (-) | NCBI | | Celera | | | Cytogenetic Map | 5 | q34 | NCBI | | | | |
|
JBrowse: |
View Region in Genome Browser (JBrowse)
|
Model |
|
References
Genomics
QTLs in Region (GRCr8)
1331796 | Thshl2 | Thyroid stimulating hormone level QTL 2 | 2.3 | | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 5 | 102105698 | 152749382 | Rat | 2303586 | Gluco52 | Glucose level QTL 52 | 2 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 5 | 100826632 | 145826632 | Rat | 1549845 | Scl44 | Serum cholesterol level QTL 44 | 6 | | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 44924861 | 153890773 | Rat | 8552960 | Pigfal15 | Plasma insulin-like growth factor 1 level QTL 15 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 116702075 | 161702075 | Rat | 70212 | Niddm25 | Non-insulin dependent diabetes mellitus QTL 25 | 3.54 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 5 | 38207390 | 136631402 | Rat | 1298070 | Scl18 | Serum cholesterol level QTL 18 | 3.7 | | blood LDL cholesterol amount (VT:0000181) | calculated plasma low density lipoprotein cholesterol level (CMO:0001245) | 5 | 84630798 | 129630798 | Rat | 61452 | Ciaa5 | CIA Autoantibody QTL 5 | 3.5 | | blood autoantibody amount (VT:0003725) | calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) | 5 | 99905133 | 172190305 | Rat | 1331801 | Rf33 | Renal function QTL 33 | 4.149 | | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 5 | 48523123 | 134369373 | Rat | 1582230 | Bw78 | Body weight QTL 78 | 3.2 | 0.0016 | epididymal fat pad mass (VT:0010421) | epididymal fat pad weight to body weight ratio (CMO:0000658) | 5 | 124314582 | 133270832 | Rat | 7411582 | Foco3 | Food consumption QTL 3 | 7.5 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 5 | 92583776 | 137583776 | Rat | 61393 | Bp7 | Blood pressure QTL 7 | 4.5 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 65089051 | 166764498 | Rat | 1598859 | Cm66 | Cardiac mass QTL 66 | 2 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 84630798 | 129630798 | Rat | 7207486 | Bss109 | Bone structure and strength QTL 109 | | | femur strength trait (VT:0010010) | femur total energy absorbed before break (CMO:0001677) | 5 | 112142946 | 157142946 | Rat | 7207481 | Bss106 | Bone structure and strength QTL 106 | 7.9 | | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 112142946 | 157142946 | Rat | 1302790 | Scl20 | Serum cholesterol level QTL 20 | 6.4 | 0.0001 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 110770739 | 155770739 | Rat | 1578766 | Tcas11 | Tongue tumor susceptibility QTL 11 | 4.12 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 5 | 51657967 | 166600247 | Rat | 1549838 | Bss4 | Bone structure and strength QTL 4 | 9.2 | | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 5 | 112142946 | 157142946 | Rat | 7411564 | Bw135 | Body weight QTL 135 | | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 92583776 | 137583776 | Rat | 8657050 | Bw146 | Body weight QTL 146 | 19.84 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 98972960 | 143972960 | Rat | 1576312 | Emca8 | Estrogen-induced mammary cancer QTL 8 | 4.1 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 5 | 55124766 | 172190305 | Rat | 7411601 | Foco12 | Food consumption QTL 12 | 19.7 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 5 | 92583776 | 137583776 | Rat | 2303618 | Vencon1 | Ventilatory control QTL 1 | 3.8 | | respiration trait (VT:0001943) | oxygen consumption (CMO:0002169) | 5 | 100826632 | 145826632 | Rat | 2317056 | Wbc3 | White blood cell count QTL 3 | 2.51 | 0.01 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 5 | 111236572 | 156236572 | Rat | 1598846 | Bp293 | Blood pressure QTL 293 | 3.9 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 84630798 | 129630798 | Rat | 7394710 | Emca12 | Estrogen-induced mammary cancer QTL 12 | | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 5 | 94034903 | 139034903 | Rat | 1598847 | Cm62 | Cardiac mass QTL 62 | 3.4 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 114131300 | 159131300 | Rat | 1358909 | Kidm25 | Kidney mass QTL 25 | 1.87 | | kidney mass (VT:0002707) | both kidneys wet weight to body weight ratio (CMO:0000340) | 5 | 95062526 | 133270832 | Rat | 70189 | Mcs5 | Mammary carcinoma susceptibility QTL 5 | 10.51 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 5 | 60601597 | 137492949 | Rat | 7207488 | Bss110 | Bone structure and strength QTL 1 | 8.4 | | femur strength trait (VT:0010010) | femur stiffness (CMO:0001674) | 5 | 112142946 | 157142946 | Rat | 8694441 | Bw169 | Body weight QTL 169 | 17.61 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 5 | 116702075 | 161702075 | Rat | 7207491 | Bss112 | Bone structure and strength QTL 112 | 7 | | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 5 | 112142946 | 157142946 | Rat | 8694389 | Bw160 | Body weight QTL 160 | 6.17 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 5 | 116702075 | 161702075 | Rat | 2290448 | Scl54 | Serum cholesterol level QTL 54 | 2.93 | | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 36460764 | 136631402 | Rat | 1354598 | Srn6 | Serum renin concentration QTL 6 | 3.8 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 5 | 74335621 | 156302135 | Rat | 1600362 | Mcs19 | Mammary carcinoma susceptibility QTL 19 | 2.5 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 5 | 82032155 | 127032155 | Rat | 8694198 | Abfw3 | Abdominal fat weight QTL 3 | 16.13 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 5 | 116702075 | 161702075 | Rat | 1298086 | Bp156 | Blood pressure QTL 156 | | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 89369373 | 134369373 | Rat | 2306971 | Anxrr21 | Anxiety related response QTL 21 | 9.47 | | fear/anxiety-related behavior trait (VT:1000241) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 5 | 70969494 | 136328156 | Rat | 1298089 | Scl14 | Serum cholesterol level QTL 14 | 5.8 | 0.0004 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 114131300 | 159131300 | Rat | 1358895 | Bp254 | Blood pressure QTL 254 | 3.6 | 0.0003 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 5 | 97492524 | 133270832 | Rat | 6903316 | Bw113 | Body weight QTL 113 | 2 | 0.0103 | body mass (VT:0001259) | body weight (CMO:0000012) | 5 | 92881678 | 137881678 | Rat | 1358889 | Bp261 | Blood pressure QTL 261 | 2.86 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 5 | 95062526 | 133270832 | Rat | 1358187 | Emca1 | Estrogen-induced mammary cancer QTL 1 | 4.4 | | mammary gland integrity trait (VT:0010552) | post-insult time to mammary tumor formation (CMO:0000345) | 5 | 104262817 | 153890625 | Rat | |
Markers in Region
PMC108483P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,577 - 11,666,050 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,748 - 120,659,098 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,746 - 125,374,095 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,309 - 13,718,781 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,322 - 15,748,794 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,139 - 129,231,488 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,783 - 126,882,132 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,536 - 12,050,008 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,909 - 13,455,381 | UniSTS | | Celera | 5 | 119,421,834 - 119,422,183 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC117781P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 5 | 120,658,755 - 120,659,098 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 12 | 11,665,577 - 11,666,043 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 12 | 13,718,309 - 13,718,774 | NCBI | Rnor6.0 | Rnor_6.0 | 5 | 125,373,753 - 125,374,095 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,322 - 15,748,787 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,146 - 129,231,488 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,790 - 126,882,132 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,536 - 12,050,001 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,909 - 13,455,374 | UniSTS | | Celera | 5 | 119,421,841 - 119,422,183 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC125345P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,577 - 11,666,050 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,748 - 120,659,098 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,746 - 125,374,095 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,309 - 13,718,781 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,322 - 15,748,794 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,139 - 129,231,488 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,783 - 126,882,132 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,536 - 12,050,008 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,909 - 13,455,381 | UniSTS | | Celera | 5 | 119,421,834 - 119,422,183 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC133829P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,577 - 11,666,050 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,748 - 120,659,098 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,746 - 125,374,095 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,309 - 13,718,781 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,322 - 15,748,794 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,139 - 129,231,488 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,783 - 126,882,132 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,536 - 12,050,008 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,909 - 13,455,381 | UniSTS | | Celera | 5 | 119,421,834 - 119,422,183 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC240671P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 5 | 120,658,784 - 120,659,043 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 12 | 11,665,632 - 11,666,014 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 12 | 13,718,364 - 13,718,745 | NCBI | Rnor6.0 | Rnor_6.0 | 5 | 125,373,782 - 125,374,040 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,377 - 15,748,758 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,175 - 129,231,433 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,819 - 126,882,077 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,591 - 12,049,972 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,964 - 13,455,345 | UniSTS | | Celera | 5 | 119,421,870 - 119,422,128 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
Actb-rs1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,660 - 11,666,072 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,727 - 120,659,015 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,725 - 125,374,012 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,392 - 13,718,803 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,405 - 15,748,816 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,118 - 129,231,405 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,762 - 126,882,049 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,619 - 12,050,030 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,992 - 13,455,403 | UniSTS | | Celera | 5 | 119,421,813 - 119,422,100 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC122623P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 5 | 120,658,789 - 120,658,908 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 12 | 11,665,887 - 11,666,009 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 12 | 13,718,619 - 13,718,740 | NCBI | Rnor6.0 | Rnor_6.0 | 5 | 125,373,787 - 125,373,905 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,632 - 15,748,753 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,180 - 129,231,298 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,824 - 126,881,942 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,846 - 12,049,967 | UniSTS | RGSC3.4 | Celera | 12 | 13,455,219 - 13,455,340 | UniSTS | | Celera | 5 | 119,421,875 - 119,421,993 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC138011P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,360 - 11,666,006 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,792 - 120,659,225 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,790 - 125,374,222 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,092 - 13,718,737 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,105 - 15,748,750 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,183 - 129,231,615 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,827 - 126,882,259 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,319 - 12,049,964 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,692 - 13,455,337 | UniSTS | | Celera | 5 | 119,421,878 - 119,422,310 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC145386P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,665,582 - 11,666,047 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,751 - 120,659,093 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,749 - 125,374,090 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,314 - 13,718,778 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,327 - 15,748,791 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,142 - 129,231,483 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,786 - 126,882,127 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,541 - 12,050,005 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,914 - 13,455,378 | UniSTS | | Celera | 5 | 119,421,837 - 119,422,178 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
PMC19354P1 |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 5 | 120,658,752 - 120,659,095 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 12 | 11,665,580 - 11,666,046 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 12 | 13,718,312 - 13,718,777 | NCBI | Rnor6.0 | Rnor_6.0 | 5 | 125,373,750 - 125,374,092 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,325 - 15,748,790 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,231,143 - 129,231,485 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,787 - 126,882,129 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,539 - 12,050,004 | UniSTS | RGSC3.4 | Celera | 12 | 13,454,912 - 13,455,377 | UniSTS | | Celera | 5 | 119,421,838 - 119,422,180 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
mActb |
Rat Assembly | Chr | Position (strand) | Source | JBrowse |
---|
mRatBN7.2 | 12 | 11,666,024 - 11,666,464 (+) | MAPPER | mRatBN7.2 | mRatBN7.2 | 5 | 120,658,368 - 120,658,774 (+) | MAPPER | mRatBN7.2 | Rnor_6.0 | 5 | 125,373,366 - 125,373,771 | NCBI | Rnor6.0 | Rnor_6.0 | 12 | 13,718,756 - 13,719,194 | NCBI | Rnor6.0 | Rnor_5.0 | 12 | 15,748,769 - 15,749,207 | UniSTS | Rnor5.0 | Rnor_5.0 | 5 | 129,230,759 - 129,231,164 | UniSTS | Rnor5.0 | RGSC_v3.4 | 5 | 126,881,403 - 126,881,808 | UniSTS | RGSC3.4 | RGSC_v3.4 | 12 | 12,049,983 - 12,050,421 | UniSTS | RGSC3.4 | Celera | 12 | 13,455,356 - 13,455,794 | UniSTS | | Celera | 5 | 119,421,454 - 119,421,859 | UniSTS | | Cytogenetic Map | 12 | p11 | UniSTS | | Cytogenetic Map | 5 | q34 | UniSTS | |
|
Expression
RNA-SEQ Expression
Sequence
Additional Information
Nomenclature History
Date |
Current Symbol |
Current Name |
Previous Symbol |
Previous Name |
Description |
Reference |
Status |
2022-06-10 |
Actb-ps9 |
actin, beta, pseudogene 9 |
LOC502977 |
similar to cytoplasmic beta-actin |
Symbol and Name Changed |
1299863 |
APPROVED |
2006-11-19 |
LOC502977 |
similar to cytoplasmic beta-actin |
|
|
Symbol and Name status set to provisional |
70820 |
PROVISIONAL |
|
|